Akebia Therapeutics, Inc. (AKBA)
0.8927
-0.12
(-11.61%)
USD |
NASDAQ |
May 19, 15:17
Akebia Therapeutics Shareholders Equity (Quarterly) : 27.38M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 491.41M |
| MannKind Corp. | -59.20M |
| United Therapeutics Corp. | 5.901B |
| Ardelyx, Inc. | 148.62M |
| Rhythm Pharmaceuticals, Inc. | 122.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 362.52M |
| Total Liabilities (Quarterly) | 335.14M |
| Debt to Equity Ratio | 7.961 |
| Current Ratio | 1.400 |
| Net Debt Paydown Yield | -1.25% |